| WP1 | Pre-eclampsia | anti-VEGF | | |
| UZH | enrolling | enrolling | | |
| KUM | approved | approved | | |
| UMA/SAS | enrolling | - | | |
| UBERN | submitted | - | | |
| WP2 | DILI | ALF | NAFLD | Methotraxate |
| UNOTT | enrolling | enrolling | enrolling | enrolling |
| UZH | enrolling | - | - | - |
| KUM | enrolling | - | - | - |
| UMA/SAS | enrolling | - | - | - |
| Landspitali | enrolling | - | - | - |
| APHP | approved | - | - | - |
| UBERN | submitted | - | - | - |
| WP3 | MAP-1 | | | |
| ULIV | submitted | | | |
| KUM | not yet submitted | | | |
| UMA/SAS | submitted | | | |
| WP4 | Vasculitides | Angioplasty | | |
| UZH | enrolling | enrolling | | |
| UMA/SAS | enrolling | - | | |
| WP5 | TBI | MS | ChemoBrain | NHV |
| Charité | - | completed | completed | completed |
| Pfizer | completed | - | - | enrolling |
enrolling: trial is running, patient recruitment is underway
approved: ethical approval has been received, patients not yet being recruited
submitted: study awaiting ethical approval, documents submitted to local ethical committee
not yet submitted: documents will be submitted for ethical approval shortly
completed: patients no longer being recruited
-: not planned/not applicable
